Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors

Cancer

Volumn 120, Issue 3, 2014, Pages 442-450

  Fisch, Michael J ^a   Zhao, Fengmin ^b   O'Mara, Ann M ^c   Wang, Xin Shelley ^a   Cella, David ^d   Cleeland, Charles S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

ambulatory care; cancer fatigue; medical oncology; symptom management

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER THERAPY; COLON CANCER; COMORBIDITY; CORTICOSTEROID THERAPY; DEPRESSION; DISEASE SEVERITY; FATIGUE; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RATING SCALE; RECTUM CANCER; SELF REPORT; SEX;

AMBULATORY CARE; CANCER FATIGUE; MEDICAL ONCOLOGY; SYMPTOM MANAGEMENT;

ADULT; AGED; AMBULATORY CARE; COMORBIDITY; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84892920350     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28437     Document Type: Article

References (47)

1. Donovan KA, McGinty HL, Jacobsen PB,. A systematic review of research using the diagnostic criteria for cancer-related fatigue. Psychooncology. 2013; 22: 737-744.
2. Berger AM, Gerber LH, Mayer DK,. Cancer-related fatigue: implications for breast cancer survivors. Cancer. 2012; 118: 2261-2269.
3. Campos MP, Hassan BJ, Riechelmann R, Del Giglio A,. Cancer-related fatigue: a practical review. Ann Oncol. 2011; 22: 1273-1279.
4. Mitchell SA,. Cancer-related fatigue: state of the science. PM R. 2010; 2: 364-383.
5. Barsevick AM, Cleeland CS, Manning DC, et al. ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage. 2010; 39: 1086-1099.
6. Berger AM, Kuhn BR, Farr LA, et al. One-year outcomes of a behavioral therapy intervention trial on sleep quality and cancer-related fatigue. J Clin Oncol. 2009; 27: 6033-6040.
7. Bruera E, El Osta B, Valero V, et al. Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol. 2007; 25: 3475-3481.
8. Bruera E, Valero V, Driver L, et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. Clin Oncol. 2006; 24: 2073-2078.
9. Cruciani RA, Zhang J, Manola JB, Cella D, Ansari B, Fisch MJ,. Phase III randomized, placebo-controlled trial of L-carnitine supplementation for fatigue in patients with cancer [abstract]. J Clin Oncol. 2009; 27S. Abstract e20532.
10. Dodd MJ, Cho MH, Miaskowski C, et al. A randomized controlled trial of home-based exercise for cancer-related fatigue in women during and after chemotherapy with or without radiation therapy. Cancer Nurs. 2010; 33: 245-257.
11. Jean-Pierre P, Morrow GR, Roscoe JA, et al. A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer. 2010; 116: 3513-3520.
12. Morrow GR, Hickok JT, Roscoe JA, et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol. 2003; 21: 4635-4641.
13. Moraska AR, Sood A, Dakhil SR, et al. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol. 2010; 28: 3673-3679.
14. Barsevick AM, Irwin MR, Hinds P, et al. Recommendations for high priority research on cancer-related fatigue in children and adults. J Natl Cancer Inst. 2013; 105: 1432-1440.
15. Berger AM, Abernethy AP, Atkinson A, et al. Cancer-related fatigue. J Natl Compr Canc Netw. 2010; 8: 904-931.
16. Andrykowski MA, Donovan KA, Jacobsen PB,. Magnitude and correlates of response shift in fatigue ratings in women undergoing adjuvant therapy for breast cancer. J Pain Symptom Manage. 2009; 37: 341-351.
17. Jacobsen PB, Donovan KA, Vadaparampil ST, Small BJ,. Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol. 2007; 26: 660-667.
18. Yennurajalingam S, Palmer JL, Chacko R, Bruera E,. Factors associated with response to methylphenidate in advanced cancer patients. Oncologist. 2011; 16: 246-253.
19. Bower JE,. Treating cancer-related fatigue: the search for interventions that target those most in need. J Clin Oncol. 2012; 30: 4449-4450.
20. Fisch MJ, Lee JW, Weiss M, et al. Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol. 2012; 30: 1980-1988.
21. Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients: the MD Anderson Symptom Inventory. Cancer. 2000; 89: 1634-1646.
22. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999; 85: 1186-1196.
23. Eastern Cooperative Oncology Group. SOAPP (Symptom Outcomes and Patient Practice Patterns): A Survey of Disease and Treatment Related Symptoms in Patients with Invasive Cancer of the Breast, Prostate, Lung, or Colon/Rectum (E2Z02). Available at: http://www.ecogsoapp.com/. Accessed on October 7, 2013.
24. Schwartz AL, Meek PM, Nail LM, et al. Measurement of fatigue. determining minimally important clinical differences. J Clin Epidemiol. 2002; 55: 239-244.
25. Andrykowski MA, Donovan KA, Laronga C, Jacobsen PB,. Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Cancer. 2010; 116: 5740-5748.
26. Andrykowski MA, Schmidt JE, Salsman JM, Beacham AO, Jacobsen PB,. Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol. 2005; 23: 6613-6622.
27. Butt Z, Wagner LI, Beaumont JL, et al. Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage. 2008; 35: 20-30.
28. Goldstein D, Bennett BK, Webber K, et al. Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort study. J Clin Oncol. 2012; 30: 1805-1812.
29. Nieboer P, Buijs C, Rodenhuis S, et al. Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study. J Clin Oncol. 2005; 23: 8296-8304.
30. Storey DJ, Waters RA, Hibberd CJ, et al. Clinically relevant fatigue in cancer outpatients: the Edinburgh Cancer Centre symptom study. Ann Oncol. 2007; 18: 1861-1869.
31. Gerber LH, Stout N, McGarvey C, et al. Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support Care Cancer. 2011; 19: 1581-1591.
32. Prue G, Allen J, Gracey J, Rankin J, Cramp F,. Fatigue in gynecological cancer patients during and after anticancer treatment. J Pain Symptom Manage. 2010; 39: 197-210.
33. Servaes P, Verhagen C, Bleijenberg G,. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer. 2002; 38: 27-43.
34. Jacobsen PB, Andrykowski MA, Thors CL,. Relationship of catastrophizing to fatigue among women receiving treatment for breast cancer. J Consult Clin Psychol. 2004; 72: 355-361.
35. Escalante CP, Manzullo EF, Lam TP, Ensor JE, Valdres RU, Wang XS,. Fatigue and its risk factors in cancer patients who seek emergency care. J Pain Symptom Manage. 2008; 36: 358-366.
36. Spratt DE, Sakae M, Riaz N, et al. Time course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapy. Oncologist. 2012; 17: 569-576.
37. Servaes P, Gielissen MF, Verhagen S, Bleijenberg G,. The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psychooncology. 2007; 16: 787-795.
38. Hickok JT, Roscoe JA, Morrow GR, Mustian K, Okunieff P, Bole CW,. Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer. 2005; 104: 1772-1778.
39. Dhruva A, Dodd M, Paul SM, et al. Trajectories of fatigue in patients with breast cancer before, during, and after radiation therapy. Cancer Nurs. 2010; 33: 201-212.
40. Armes J, Chalder T, Addington-Hall J, Richardson A, Hotopf M,. A randomized controlled trial to evaluate the effectiveness of a brief, behaviorally oriented intervention for cancer-related fatigue. Cancer. 2007; 110: 1385-1395.
41. Kim SH, Son BH, Hwang SY, et al. Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life. J Pain Symptom Manage. 2008; 35: 644-655.
42. Barsevick A, Cella D,. NCI Symptom Management and Quality of Life Steering Committee Clinical Trials Planning Conference: Cancer-Related Fatigue. Bethesda, MD: National Institutes of Health; 2010.
43. Joly F, Vardy J, Pintilie M, Tannock IF,. Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Ann Oncol. 2007; 18: 1935-1942.
44. Lower EE, Fleishman S, Cooper A, et al. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J Pain Symptom Manage. 2009; 38: 650-662.
45. Lower EE, Malhotra A, Surdulescu V, Baughman RP,. Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial. J Pain Symptom Manage. 2013; 45: 159-169.
46. Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J,. A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med. 2001; 161: 411-420.
47. Yennurajalingam S, Frisbee-Hume S, Palmer JL, et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol. 2013; 31: 3076-3082.